With the advent of angiotensin-converting enzyme inhibitors to treat the SSc renal crisis, SSc-associated pulmonary arterial hypertension (SSc-PAH) has emerged as a leading cause of morbidity and mortality of premature deaths. Here, ACE is linked to systemic sclerosis.